Thromboxane A2 mimetic (U-46619) induces hyperresponsiveness of smooth muscle in the canine bronchiole, but not in the trachea

S. Takata, H. Aizawa, M. Shigyo, Koichiro Matsumoto, H. Inoue, H. Koto, N. Hara

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

It has been reported that cholinergic agonists induce bronchoconstriction by directly stimulating M, muscarinic receptors on the surfaces of smooth muscle cells. Although thromboxane A2 (TXA2) has been demonstrated to induce airway hyperresponsiveness to cholinergic agonists in vivo, it does not affect the contractile response of smooth muscle to cholinergic agonists in vitro. To investigate the causes for the discrepancy between the in vivo and in vitro data, we compared the effects exerted by a TXA2 mimetic, U-46619, on the smooth muscle of canine trachea and bronchiole. We measured the contractile response to exogenously applied acetylcholine (ACh) before and after the application of a subthreshold dose of U-46619. The subthreshold dose was determined as that dose which did not induce smooth muscle contraction, this being 10-9 M in the present study. The contractile responses of tracheal strips to ACh were not affected by the subthreshold dose of U-46619. By contrast, the responses of bronchiolar rings were significantly enhanced by this subthreshold dose. The excitatory effect of U-46619 on the ACh-induced contraction was completely prevented by treatment with a TXA2 antagonist, BAY u3405. These results indicate that TXA2 directly increases the responsiveness of smooth muscle in the bronchiole, and suggest that increases in the responsiveness of small airways may play an important role in the development of the airway hyperresponsiveness induced by TXA2.

Original languageEnglish
Pages (from-to)129-134
Number of pages6
JournalProstaglandins Leukotrienes and Essential Fatty Acids
Volume54
Issue number2
DOIs
Publication statusPublished - Jan 1 1996

Fingerprint

Bronchioles
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Thromboxane A2
Trachea
Smooth Muscle
Muscle
Canidae
Cholinergic Agonists
Acetylcholine
Bronchoconstriction
Muscarinic Receptors
Muscle Contraction
Smooth Muscle Myocytes
Cells

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry
  • Cell Biology

Cite this

Thromboxane A2 mimetic (U-46619) induces hyperresponsiveness of smooth muscle in the canine bronchiole, but not in the trachea. / Takata, S.; Aizawa, H.; Shigyo, M.; Matsumoto, Koichiro; Inoue, H.; Koto, H.; Hara, N.

In: Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 54, No. 2, 01.01.1996, p. 129-134.

Research output: Contribution to journalArticle

@article{1efbeb47a40a43d1b1649fdaf7fb4496,
title = "Thromboxane A2 mimetic (U-46619) induces hyperresponsiveness of smooth muscle in the canine bronchiole, but not in the trachea",
abstract = "It has been reported that cholinergic agonists induce bronchoconstriction by directly stimulating M, muscarinic receptors on the surfaces of smooth muscle cells. Although thromboxane A2 (TXA2) has been demonstrated to induce airway hyperresponsiveness to cholinergic agonists in vivo, it does not affect the contractile response of smooth muscle to cholinergic agonists in vitro. To investigate the causes for the discrepancy between the in vivo and in vitro data, we compared the effects exerted by a TXA2 mimetic, U-46619, on the smooth muscle of canine trachea and bronchiole. We measured the contractile response to exogenously applied acetylcholine (ACh) before and after the application of a subthreshold dose of U-46619. The subthreshold dose was determined as that dose which did not induce smooth muscle contraction, this being 10-9 M in the present study. The contractile responses of tracheal strips to ACh were not affected by the subthreshold dose of U-46619. By contrast, the responses of bronchiolar rings were significantly enhanced by this subthreshold dose. The excitatory effect of U-46619 on the ACh-induced contraction was completely prevented by treatment with a TXA2 antagonist, BAY u3405. These results indicate that TXA2 directly increases the responsiveness of smooth muscle in the bronchiole, and suggest that increases in the responsiveness of small airways may play an important role in the development of the airway hyperresponsiveness induced by TXA2.",
author = "S. Takata and H. Aizawa and M. Shigyo and Koichiro Matsumoto and H. Inoue and H. Koto and N. Hara",
year = "1996",
month = "1",
day = "1",
doi = "10.1016/S0952-3278(96)90070-8",
language = "English",
volume = "54",
pages = "129--134",
journal = "Prostaglandins Leukotrienes and Essential Fatty Acids",
issn = "0952-3278",
publisher = "Churchill Livingstone",
number = "2",

}

TY - JOUR

T1 - Thromboxane A2 mimetic (U-46619) induces hyperresponsiveness of smooth muscle in the canine bronchiole, but not in the trachea

AU - Takata, S.

AU - Aizawa, H.

AU - Shigyo, M.

AU - Matsumoto, Koichiro

AU - Inoue, H.

AU - Koto, H.

AU - Hara, N.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - It has been reported that cholinergic agonists induce bronchoconstriction by directly stimulating M, muscarinic receptors on the surfaces of smooth muscle cells. Although thromboxane A2 (TXA2) has been demonstrated to induce airway hyperresponsiveness to cholinergic agonists in vivo, it does not affect the contractile response of smooth muscle to cholinergic agonists in vitro. To investigate the causes for the discrepancy between the in vivo and in vitro data, we compared the effects exerted by a TXA2 mimetic, U-46619, on the smooth muscle of canine trachea and bronchiole. We measured the contractile response to exogenously applied acetylcholine (ACh) before and after the application of a subthreshold dose of U-46619. The subthreshold dose was determined as that dose which did not induce smooth muscle contraction, this being 10-9 M in the present study. The contractile responses of tracheal strips to ACh were not affected by the subthreshold dose of U-46619. By contrast, the responses of bronchiolar rings were significantly enhanced by this subthreshold dose. The excitatory effect of U-46619 on the ACh-induced contraction was completely prevented by treatment with a TXA2 antagonist, BAY u3405. These results indicate that TXA2 directly increases the responsiveness of smooth muscle in the bronchiole, and suggest that increases in the responsiveness of small airways may play an important role in the development of the airway hyperresponsiveness induced by TXA2.

AB - It has been reported that cholinergic agonists induce bronchoconstriction by directly stimulating M, muscarinic receptors on the surfaces of smooth muscle cells. Although thromboxane A2 (TXA2) has been demonstrated to induce airway hyperresponsiveness to cholinergic agonists in vivo, it does not affect the contractile response of smooth muscle to cholinergic agonists in vitro. To investigate the causes for the discrepancy between the in vivo and in vitro data, we compared the effects exerted by a TXA2 mimetic, U-46619, on the smooth muscle of canine trachea and bronchiole. We measured the contractile response to exogenously applied acetylcholine (ACh) before and after the application of a subthreshold dose of U-46619. The subthreshold dose was determined as that dose which did not induce smooth muscle contraction, this being 10-9 M in the present study. The contractile responses of tracheal strips to ACh were not affected by the subthreshold dose of U-46619. By contrast, the responses of bronchiolar rings were significantly enhanced by this subthreshold dose. The excitatory effect of U-46619 on the ACh-induced contraction was completely prevented by treatment with a TXA2 antagonist, BAY u3405. These results indicate that TXA2 directly increases the responsiveness of smooth muscle in the bronchiole, and suggest that increases in the responsiveness of small airways may play an important role in the development of the airway hyperresponsiveness induced by TXA2.

UR - http://www.scopus.com/inward/record.url?scp=0029665810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029665810&partnerID=8YFLogxK

U2 - 10.1016/S0952-3278(96)90070-8

DO - 10.1016/S0952-3278(96)90070-8

M3 - Article

C2 - 8848432

AN - SCOPUS:0029665810

VL - 54

SP - 129

EP - 134

JO - Prostaglandins Leukotrienes and Essential Fatty Acids

JF - Prostaglandins Leukotrienes and Essential Fatty Acids

SN - 0952-3278

IS - 2

ER -